Close Menu

NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Wednesday that its first quarter revenues increased 27 percent year over year.

For the three months ended March 31, the San Diego-based liquid biopsy firm saw $1.0 million in revenues compared to $806,943 a year ago. These included about $976,000 in commercial test revenues and $42,000 from development services testing. The firm posted $6,000 in other revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

One gene regulates hundreds of others to influence facial development, according to New Scientist.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.